Kulika Weizman is a General Partner at Creative Ventures, overseeing investment research and strategy in healthcare and biotechnology. She previously co-founded and led a synthetic biology startup from her UC Berkeley research.
At firms with a similar stage, sector and check size.
One email when Kulika's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckKulika Weizman is a General Partner at Creative Ventures, overseeing investment research and strategy in healthcare and biotechnology. She previously co-founded and led a synthetic biology startup from her UC Berkeley research.
Creative Ventures has not reported a check size. It invests at seed, series a.
Email [email protected], the firm's inbox for founders, and name Kulika in the subject. A warm intro from a founder Creative Ventures backed works better.
Last updated 2026-10-15. Is this you? Ask for a correction.